Prophylaxis for von Willebrand disease: Is it time for parity with established practice in hemophilia A?
Therapeutic Advances in Hematology
Published online on April 05, 2026
Abstract
Therapeutic Advances in Hematology, Volume 17, January-December 2026.
A deficiency and/or dysfunction of von Willebrand factor (VWF) or factor VIII (FVIII) results in the bleeding disorders of von Willebrand disease (VWD) and hemophilia A (HA), respectively. Whereas HA impacts coagulation, VWD primarily impairs hemostasis ...
A deficiency and/or dysfunction of von Willebrand factor (VWF) or factor VIII (FVIII) results in the bleeding disorders of von Willebrand disease (VWD) and hemophilia A (HA), respectively. Whereas HA impacts coagulation, VWD primarily impairs hemostasis ...